Home Uncategorized People testing negative for Covid-19 despite exposure may have ‘immune memory’

People testing negative for Covid-19 despite exposure may have ‘immune memory’


People testing negative for Covid-19 despite exposure may have ‘immune memory’


People testing negative for Covid-19 despite exposure may have ‘immune memory’

Study says some individuals clear virus rapidly due to a strong immune response from existing T-cells, meaning tests record negative result

  • Coronavirus – latest updates
  • See all our coronavirus coverage
Human T-cell, from a healthy donor

The work suggests that a subset of people already had memory T-cells from previous infections from other seasonal coronaviruses causing common colds, which protected them from Covid-19.

These immune cells “sniff out” proteins in the replication machinery – a region of Covid-19 shared with seasonal coronaviruses – and in some people this response was quick and potent enough for the infection to be cleared at the earliest stage. “These pre-existing T-cells are poised ready to recognise SARS-CoV-2,” said Swadling.

The study adds to the known spectrum of possibilities after exposure to Covid-19, ranging from escaping infection entirely to severe disease.

Alexander Edwards, associate professor in biomedical technology at the University of Reading, said: “This study identifies [a new] intermediate outcome – enough virus exposure to activate part of your immune system but not enough to experience symptoms, detect significant levels of virus or mount an antibody response.”

The finding is particularly significant because the T-cell arm of the immune response tends to confer longer lasting immunity, typically of years rather than months, compared with antibodies. Nearly all existing Covid-19 vaccines focus on priming antibodies against the vital spike protein that helps SARS-CoV-2 enter cells. These neutralising antibodies give excellent protection against severe illness. However, the immunity wanes over time and a potential weakness of spike-based vaccines is that this region of the virus is known to mutate.

By contrast, the T-cell response does not tend to fade as quickly and the internal replication machinery that it targets is highly conserved across coronaviruses, meaning a vaccine that also targeted this region would probably protect against new strains – and possibly even against entirely new pathogens.

“Insights from this study could be critical in design of a different type of vaccine,” said Andrew Freedman, reader in infectious diseases at Cardiff University School of Medicine. “A vaccine that primes T-cell immunity against different viral protein targets that are shared between many different coronaviruses would complement our spike vaccines that induce neutralising antibodies. Because these are components within the virus, antibodies are less effective – instead, T-cells come into play.”


  • Coronavirus
  • Medical research
  • Microbiology
  • Vaccines and immunisation
  • Infectious diseases
  • Biology
  • Epidemics
  • news
  • ” target=”_blank” rel=”noreferrer” data-ignore=”global-link-styling”>
Reuse this content

Published at Wed, 10 Nov 2021 16:45:28 +0000


Previous articleChina’s ‘Battle at Lake Changjin’ Marching to North American, Australian Release
Next articleMigrants Say They Face Abuse on Both Sides of Belarus Border